A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine

C. Rory Goodwin, Vijay Yanamadala, Alejandro Ruiz-Valls, Nancy Abu-Bonsrah, Ganesh Shankar, Eric W. Sankey, Christine Boone, Michelle J. Clarke, Mark Bilsky, Ilya Laufer, Charles Fisher, John H. Shin, Daniel Sciubba

Research output: Contribution to journalArticle

Abstract

Background: Hepatocellular carcinoma (HCC) frequently metastasizes to the spine. The impact of medical and/or surgical intervention on overall survival has been examined in a limited number of clinical studies, and herein we systematically review these data. Methods: We performed a literature review using PubMed, Embase, CINAHL, and Web of Science to identify articles that reported survival, clinical outcomes, and/or prognostic factors associated with patients diagnosed with spinal metastases. The methodologic quality of each review was assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses tool. Results: There were 26 articles (152 patients) that met the inclusion criteria and were treated with either surgery, radiotherapy, chemotherapy, and/or observation. There were 3 retrospective cohort studies, 17 case reports, 5 case series, and 1 longitudinal observational study. Of the patients with known overall survival after diagnosis of spinal metastasis, survival at 3 months, 6 months, 1 year, 2 years, and 5 years was 95.2%, 83.0%, 28.6%, 2.0%, and 1.4%, respectively. The median survival after diagnosis of the metastasis was 0.7 months in the patients who received no treatment, 7 months in the patients treated with surgical intervention alone, 6 months for patients who received chemotherapy and/or radiation, and 13.5 months in the patients treated with a combination of surgery and medical management. All other clinical or prognostic parameters were of low or insufficient strength. Conclusions: Patients diagnosed with HCC spinal metastasis have a 10.6-month overall survival. Further analysis of patients in prospective controlled trials will be essential to the development of treatment algorithms for these patients in the future.

Original languageEnglish (US)
JournalWorld Neurosurgery
DOIs
StateAccepted/In press - Feb 19 2016

Fingerprint

Hepatocellular Carcinoma
Spine
Survival
Neoplasm Metastasis
Drug Therapy
PubMed
Observational Studies
Longitudinal Studies
Meta-Analysis
Cohort Studies
Radiotherapy
Retrospective Studies
Observation
Radiation
Therapeutics

Keywords

  • Hepatocellular carcinoma
  • Liver cancer
  • Spine metastasis
  • Surgery
  • Survival
  • Tumor

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Goodwin, C. R., Yanamadala, V., Ruiz-Valls, A., Abu-Bonsrah, N., Shankar, G., Sankey, E. W., ... Sciubba, D. (Accepted/In press). A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. World Neurosurgery. https://doi.org/10.1016/j.wneu.2016.04.026

A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. / Goodwin, C. Rory; Yanamadala, Vijay; Ruiz-Valls, Alejandro; Abu-Bonsrah, Nancy; Shankar, Ganesh; Sankey, Eric W.; Boone, Christine; Clarke, Michelle J.; Bilsky, Mark; Laufer, Ilya; Fisher, Charles; Shin, John H.; Sciubba, Daniel.

In: World Neurosurgery, 19.02.2016.

Research output: Contribution to journalArticle

Goodwin, CR, Yanamadala, V, Ruiz-Valls, A, Abu-Bonsrah, N, Shankar, G, Sankey, EW, Boone, C, Clarke, MJ, Bilsky, M, Laufer, I, Fisher, C, Shin, JH & Sciubba, D 2016, 'A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine', World Neurosurgery. https://doi.org/10.1016/j.wneu.2016.04.026
Goodwin CR, Yanamadala V, Ruiz-Valls A, Abu-Bonsrah N, Shankar G, Sankey EW et al. A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. World Neurosurgery. 2016 Feb 19. https://doi.org/10.1016/j.wneu.2016.04.026
Goodwin, C. Rory ; Yanamadala, Vijay ; Ruiz-Valls, Alejandro ; Abu-Bonsrah, Nancy ; Shankar, Ganesh ; Sankey, Eric W. ; Boone, Christine ; Clarke, Michelle J. ; Bilsky, Mark ; Laufer, Ilya ; Fisher, Charles ; Shin, John H. ; Sciubba, Daniel. / A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. In: World Neurosurgery. 2016.
@article{671720a430ec44b39007edc5c83a07fe,
title = "A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine",
abstract = "Background: Hepatocellular carcinoma (HCC) frequently metastasizes to the spine. The impact of medical and/or surgical intervention on overall survival has been examined in a limited number of clinical studies, and herein we systematically review these data. Methods: We performed a literature review using PubMed, Embase, CINAHL, and Web of Science to identify articles that reported survival, clinical outcomes, and/or prognostic factors associated with patients diagnosed with spinal metastases. The methodologic quality of each review was assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses tool. Results: There were 26 articles (152 patients) that met the inclusion criteria and were treated with either surgery, radiotherapy, chemotherapy, and/or observation. There were 3 retrospective cohort studies, 17 case reports, 5 case series, and 1 longitudinal observational study. Of the patients with known overall survival after diagnosis of spinal metastasis, survival at 3 months, 6 months, 1 year, 2 years, and 5 years was 95.2{\%}, 83.0{\%}, 28.6{\%}, 2.0{\%}, and 1.4{\%}, respectively. The median survival after diagnosis of the metastasis was 0.7 months in the patients who received no treatment, 7 months in the patients treated with surgical intervention alone, 6 months for patients who received chemotherapy and/or radiation, and 13.5 months in the patients treated with a combination of surgery and medical management. All other clinical or prognostic parameters were of low or insufficient strength. Conclusions: Patients diagnosed with HCC spinal metastasis have a 10.6-month overall survival. Further analysis of patients in prospective controlled trials will be essential to the development of treatment algorithms for these patients in the future.",
keywords = "Hepatocellular carcinoma, Liver cancer, Spine metastasis, Surgery, Survival, Tumor",
author = "Goodwin, {C. Rory} and Vijay Yanamadala and Alejandro Ruiz-Valls and Nancy Abu-Bonsrah and Ganesh Shankar and Sankey, {Eric W.} and Christine Boone and Clarke, {Michelle J.} and Mark Bilsky and Ilya Laufer and Charles Fisher and Shin, {John H.} and Daniel Sciubba",
year = "2016",
month = "2",
day = "19",
doi = "10.1016/j.wneu.2016.04.026",
language = "English (US)",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine

AU - Goodwin, C. Rory

AU - Yanamadala, Vijay

AU - Ruiz-Valls, Alejandro

AU - Abu-Bonsrah, Nancy

AU - Shankar, Ganesh

AU - Sankey, Eric W.

AU - Boone, Christine

AU - Clarke, Michelle J.

AU - Bilsky, Mark

AU - Laufer, Ilya

AU - Fisher, Charles

AU - Shin, John H.

AU - Sciubba, Daniel

PY - 2016/2/19

Y1 - 2016/2/19

N2 - Background: Hepatocellular carcinoma (HCC) frequently metastasizes to the spine. The impact of medical and/or surgical intervention on overall survival has been examined in a limited number of clinical studies, and herein we systematically review these data. Methods: We performed a literature review using PubMed, Embase, CINAHL, and Web of Science to identify articles that reported survival, clinical outcomes, and/or prognostic factors associated with patients diagnosed with spinal metastases. The methodologic quality of each review was assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses tool. Results: There were 26 articles (152 patients) that met the inclusion criteria and were treated with either surgery, radiotherapy, chemotherapy, and/or observation. There were 3 retrospective cohort studies, 17 case reports, 5 case series, and 1 longitudinal observational study. Of the patients with known overall survival after diagnosis of spinal metastasis, survival at 3 months, 6 months, 1 year, 2 years, and 5 years was 95.2%, 83.0%, 28.6%, 2.0%, and 1.4%, respectively. The median survival after diagnosis of the metastasis was 0.7 months in the patients who received no treatment, 7 months in the patients treated with surgical intervention alone, 6 months for patients who received chemotherapy and/or radiation, and 13.5 months in the patients treated with a combination of surgery and medical management. All other clinical or prognostic parameters were of low or insufficient strength. Conclusions: Patients diagnosed with HCC spinal metastasis have a 10.6-month overall survival. Further analysis of patients in prospective controlled trials will be essential to the development of treatment algorithms for these patients in the future.

AB - Background: Hepatocellular carcinoma (HCC) frequently metastasizes to the spine. The impact of medical and/or surgical intervention on overall survival has been examined in a limited number of clinical studies, and herein we systematically review these data. Methods: We performed a literature review using PubMed, Embase, CINAHL, and Web of Science to identify articles that reported survival, clinical outcomes, and/or prognostic factors associated with patients diagnosed with spinal metastases. The methodologic quality of each review was assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses tool. Results: There were 26 articles (152 patients) that met the inclusion criteria and were treated with either surgery, radiotherapy, chemotherapy, and/or observation. There were 3 retrospective cohort studies, 17 case reports, 5 case series, and 1 longitudinal observational study. Of the patients with known overall survival after diagnosis of spinal metastasis, survival at 3 months, 6 months, 1 year, 2 years, and 5 years was 95.2%, 83.0%, 28.6%, 2.0%, and 1.4%, respectively. The median survival after diagnosis of the metastasis was 0.7 months in the patients who received no treatment, 7 months in the patients treated with surgical intervention alone, 6 months for patients who received chemotherapy and/or radiation, and 13.5 months in the patients treated with a combination of surgery and medical management. All other clinical or prognostic parameters were of low or insufficient strength. Conclusions: Patients diagnosed with HCC spinal metastasis have a 10.6-month overall survival. Further analysis of patients in prospective controlled trials will be essential to the development of treatment algorithms for these patients in the future.

KW - Hepatocellular carcinoma

KW - Liver cancer

KW - Spine metastasis

KW - Surgery

KW - Survival

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84967318139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967318139&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2016.04.026

DO - 10.1016/j.wneu.2016.04.026

M3 - Article

C2 - 27090971

AN - SCOPUS:84967318139

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

ER -